The results showed a significantly higher positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients compared with serum antibodies (IgM, IgG, IgA and NAb) (all P < 0.001). This evidence concerns the gene CD79A and COVID-19.